Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 9, 1999 - Issue 5
Submit an article Journal homepage
12
Views
1
CrossRef citations to date
0
Altmetric
Review

The inhibition of isoforms of nitric oxide synthase: non-cardiovascular aspects

Barnett S Pitzele Searle, 4901 Searle Parkway, Skokie, IL 60077, USA
Pages 549-556 | Published online: 25 Feb 2005

Bibliography

  • PFIZER, INC: US product prescribing information for Viagra® brand of sildenafll citrate. http://www.pfizer.com/hml/pfs/viagrapi.html
  • MICHEL T, FERON O: Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. (1997) 100:2146–2152.
  • NATHAN C: Inducible nitric oxide synthase: what dif-ference does it make? J. Clin. Invest. (1997) 100:2417–2423.
  • CHRISTOPHERSON KS, BREDT DS: Nitric oxide in excit-able tissues: physiological roles and disease. J. Clin. In-vest. (1997) 100:2424–2429.
  • FRETLAND DJ, CONNOR JR, PITZELE BS et al.: Inhibition of nitric oxide synthase and prospects for therapy in inflammatory diseases. Curr. Pharm. Design (1997) 3:447–462.
  • MOORE PK, HANDY RLC: Selective inhibitors of neu-ronal nitric oxide synthase-is no NOS really good NOS for the nervous system? Trends Pharmacol Sci. (1997) 18:204–210.
  • STOCLET J-C, TRONCY E, MULLER B et al: Molecularmechanisms underlying the role of nitric oxide in the cardiovascular system. Exp. Opin. Invest. Drugs (1998) 7:1769–1779.
  • PITZELE BS: The modulation of the action of isoformsof nitric oxide synthase. Exp. Opin. Ther. Patents (1997) 7:717–727.
  • HANSEN DW, JR.: Nitric oxide synthase inhibitors with cardiovascular therapeutic potential Exp. Opin. Ther. Patents (1999) 9(5):537–547.
  • GRANT SK, GREEN BG, STIFFEY-WILUSZ J et al.: Struc-tural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Biochemistry (1998) 37:4174–4180.
  • FAST W, NIKOLIC D, VAN BREEMEN RB et al.: Mechanis-tic studies of the inactivation of inducible nitric oxide synthase by N5-0.-Iminoethy04-ornithine (t-NI0). J. Am. Chem. Soc. (1999) 121:903–916.
  • SHANKARAN K, DONNELLY KL, SHAH SK et al.: Inhibi-tion of nitric oxide synthase by benzoxazolones. Bioorg. Med. Chem. Lett. (1997) 7:2887–2892.
  • SHEARER BG, LEE S, OPLINGER JA et al: Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. J. Merl. Chem. (1997) 40:1901–1905.
  • COLLINS, JL, SHEARER, BG, OPLINGER, JA et al: N-Phenylamidines as selective inhibitors of human neu-ronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. J. Merl. Chem. (1998) 41:2858–2871.
  • COWART M, KOWALUK EA, DAANEN JF et al.: Nitroaro-matic amino acids as inhibitors of neuronal nitric ox-ide synthase. J. Merl. Chem. (1998) 41:2636–2642.
  • HALLINAN EA, TSYMBALOV S, FINNEGAN PM et al.: Aceta-m id ine lysine derivative, N-(5 (S)-amino-6,7-dihydroxyheptyflethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase. J. Med. Chem. (1998) 41:775–777.
  • HAGEN TJ, BERGMANIS AA, KRAMER SW et al.: 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase. J. Med. Chem. (1998) 41:3675–3683.
  • WEBBER RK, METZ S, MOORE WM et al.: Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. J. Med. Chem. (1998) 41:96–101.
  • HANSEN DW, JR., PETERSON KB, TRIVEDI M et al.: 2-Iminohomopiperidine salts as selective inhibitors of inducible nitric oxide synthase (iNOS). J. Merl. Chem. (1998) 41:1361–1366.
  • FISCHMANN TO, HRUZA A, DA NIU X et al: Structural characterization of nitric oxide synthase isoforms re-veals striking active-site conservation. Nature Struct. Biol. (1999) 6:233–242.
  • ••A detailed description of the oxidase region crystal struc-tures of human iNOS and eNOS, with ligands included.
  • COSENTINO F, PATTON S, D'USCIO LV eta].: Tetrahydro-biopterin alters superoxide and nitric oxide release in prehypertensive rats. J. Clin. Invest. (1998) 101:1530–1537.
  • BOMMEL HM, REIF A, FROHLICH LG et al.: Anti-pterins astools to characterize the function of tetrahydrobiop-terin in NO synthase. J. Biol. Chem. (1998) 273:33142-33149. Glaxo Wellcome has problems in sepsis. Scrip (1998) 2330:21. MOORE WM, WEBBER RK, JEROME GM et al.: t-NG-(1-IminoethyOlysine: a selective inhibitor of inducible nitric oxide synthase. J. Merl. Chem. (1994) 37:3886–3888.
  • ASHINA M, LASSEN LH, BENDTSEN L eta].: Effect of inhi-bition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 353:287–289.
  • http://www.biospce.com/b2/industry/publications/ BioVentureView.cfm Bio Venture View. Robbins-Roth C (Ed.) (1998) 13:14. 27.Scrip (1996) 2138:6.
  • Genentech Corp. Press release (22 January 1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.